We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Second Course of Therapy for Resistant Patent Ductus Arteriosus (PDA)

This study has been withdrawn prior to enrollment.
(Changes in approach to PDA therapy)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01070745
First Posted: February 18, 2010
Last Update Posted: June 7, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Shaare Zedek Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: No date given
  Estimated Primary Completion Date: June 2012 (Final data collection date for primary outcome measure)